Brittany L Moyce Gruber1,2, Laura K Cole1,2, Bo Xiang1,2, Mario A Fonseca1,2, Julianne Klein3, Grant M Hatch1,2, Christine A Doucette2,4, Vernon W Dolinsky5,6. 1. Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, MB, Canada. 2. Diabetes Research Envisioned and Accomplished in Manitoba (DREAM) Research Theme of the Children's Hospital Research Institute of Manitoba, University of Manitoba, Winnipeg, MB, Canada. 3. Diagnostic Services of Manitoba, Winnipeg, MB, Canada. 4. Department of Physiology and Pathophysiology, University of Manitoba, Winnipeg, MB, Canada. 5. Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, MB, Canada. vdolinsky@chrim.ca. 6. Diabetes Research Envisioned and Accomplished in Manitoba (DREAM) Research Theme of the Children's Hospital Research Institute of Manitoba, University of Manitoba, Winnipeg, MB, Canada. vdolinsky@chrim.ca.
Abstract
AIMS/HYPOTHESIS: Obesity and hepatic steatosis are risk factors for gestational diabetes mellitus (GDM), a common complication of pregnancy. Adiponectin is a fat-derived hormone that improves hepatic steatosis and insulin sensitivity. Low levels of circulating adiponectin are associated with GDM development. We hypothesised that adiponectin deficiency causes fatty liver during pregnancy, contributing to the development of GDM. METHODS: To determine the role of adiponectin in fatty liver development during pregnancy, we compared pregnant (third week of pregnancy) adiponectin knockout (KO) mice (strain B6;129-Adipoqtm1Chan/J) with wild-type mice and assessed several variables of hepatic lipid metabolism and glucose homeostasis. The impact of adiponectin supplementation was measured by administering adenovirus-mediated full-length adiponectin at the end of the second week of pregnancy and comparing with green fluorescent protein control. RESULTS: In the third week of pregnancy, fasted pregnant adiponectin KO mice were hyperglycaemic on a low-fat diet (9.2 mmol/l vs 7.7 mmol/l in controls, p<0.05) and were glucose and pyruvate intolerant relative to wild-type mice. Pregnant adiponectin KO mice developed hepatic steatosis and a threefold elevation in hepatic triacylglycerols (p<0.05) relative to wild-type mice. Gestational weight gain and food consumption were similar in KO and wild-type mice. Adenoviral-mediated adiponectin supplementation to pregnant adiponectin KO mice improved glucose tolerance, prevented fasting hyperglycaemia and attenuated fatty liver development. CONCLUSIONS/ INTERPRETATION: Adiponectin deficiency increased hepatic lipid accumulation during the period of pregnancy associated with increased fat utilisation. Consequently, adiponectin deficiency contributed to glucose intolerance, dysregulated gluconeogenesis and hyperglycaemia, all of which are characteristic of GDM. Increasing adiponectin in the last week of pregnancy alleviated hepatic steatosis and restored normal glucose homeostasis during pregnancy.
AIMS/HYPOTHESIS: Obesity and hepatic steatosis are risk factors for gestational diabetes mellitus (GDM), a common complication of pregnancy. Adiponectin is a fat-derived hormone that improves hepatic steatosis and insulin sensitivity. Low levels of circulating adiponectin are associated with GDM development. We hypothesised that adiponectin deficiency causes fatty liver during pregnancy, contributing to the development of GDM. METHODS: To determine the role of adiponectin in fatty liver development during pregnancy, we compared pregnant (third week of pregnancy) adiponectin knockout (KO) mice (strain B6;129-Adipoqtm1Chan/J) with wild-type mice and assessed several variables of hepatic lipid metabolism and glucose homeostasis. The impact of adiponectin supplementation was measured by administering adenovirus-mediated full-length adiponectin at the end of the second week of pregnancy and comparing with green fluorescent protein control. RESULTS: In the third week of pregnancy, fasted pregnant adiponectin KO mice were hyperglycaemic on a low-fat diet (9.2 mmol/l vs 7.7 mmol/l in controls, p<0.05) and were glucose and pyruvate intolerant relative to wild-type mice. Pregnant adiponectin KO mice developed hepatic steatosis and a threefold elevation in hepatic triacylglycerols (p<0.05) relative to wild-type mice. Gestational weight gain and food consumption were similar in KO and wild-type mice. Adenoviral-mediated adiponectin supplementation to pregnant adiponectin KO mice improved glucose tolerance, prevented fasting hyperglycaemia and attenuated fatty liver development. CONCLUSIONS/ INTERPRETATION: Adiponectin deficiency increased hepatic lipid accumulation during the period of pregnancy associated with increased fat utilisation. Consequently, adiponectin deficiency contributed to glucose intolerance, dysregulated gluconeogenesis and hyperglycaemia, all of which are characteristic of GDM. Increasing adiponectin in the last week of pregnancy alleviated hepatic steatosis and restored normal glucose homeostasis during pregnancy.
Authors: Prasoon Agarwal; Taylor S Morriseau; Stephanie M Kereliuk; Christine A Doucette; Brandy A Wicklow; Vernon W Dolinsky Journal: Crit Rev Clin Lab Sci Date: 2018-01-08 Impact factor: 6.250
Authors: Seung Mi Lee; Soo Heon Kwak; Ja Nam Koo; Ig Hwan Oh; Jeong Eun Kwon; Byoung Jae Kim; Sun Min Kim; Sang Youn Kim; Gyoung Min Kim; Sae Kyung Joo; Bo Kyung Koo; Sue Shin; Chanthalakeo Vixay; Errol R Norwitz; Chan-Wook Park; Jong Kwan Jun; Won Kim; Joong Shin Park Journal: Diabetologia Date: 2018-11-23 Impact factor: 10.122
Authors: Natasha L Brooks; Chad M Trent; Carl F Raetzsch; Kevin Flurkey; Gunnar Boysen; Michael T Perfetti; Yo-Chan Jeong; Simon Klebanov; Kajal B Patel; Valerie R Khodush; Lawrence L Kupper; David Carling; James A Swenberg; David E Harrison; Terry P Combs Journal: J Biol Chem Date: 2007-09-28 Impact factor: 5.157
Authors: L R De Souza; H Berger; R Retnakaran; P A Vlachou; J L Maguire; A B Nathens; P W Connelly; J G Ray Journal: Nutr Diabetes Date: 2016-09-19 Impact factor: 5.097
Authors: Man Mohan Shrestha; Sanne Wermelin; Elisabet Stener-Victorin; Ingrid Wernstedt Asterholm; Anna Benrick Journal: Int J Mol Sci Date: 2022-04-29 Impact factor: 6.208